Burnout, anxiety that never clocks out, alcohol doing quiet overtime — the people who hold everything together are often the last to get help. There are serious, discreet, well-run options. We know which ones.
Yes. Programs run 7–10 days abroad, are planned around your calendar and are private by design — no insurer, no employer, no record beyond the clinic's. We handle screening, clinic selection and logistics quietly; you decide who knows. The hard part is deciding to stop for ten days.
The version of struggle that comes with a calendar and a team looks different. It’s still struggle.
The professional’s obstacles are specific: time, visibility, and the fear that asking for help reads as weakness in rooms where it can’t. So the plan has to be specific too — a program that fits a real calendar, a provider that treats confidentiality as seriously as medicine, and a story you control.
Clinically, the options are stronger than most executives expect. Ketamine therapy is legal in the U.S. and schedulable around work. For alcohol or opioid dependence, ibogaine’s single supervised experience — at a clinic that runs genuine cardiac screening, since that’s where its serious risks concentrate in unscreened pre-existing conditions — compresses what standard care spreads over months.
We handle the diligence you’d apply to any major decision: which providers clear our bar, what the fee actually covers, and what the weeks before and after should look like. You bring the decision; we bring the vetting.
The research most relevant to high-performers isn’t about illness — it’s about capacity:
Leadership and connection. A 2023 study in Frontiers in Psychology comparing leaders with and without psychedelic experience found the experienced group scored significantly higher on Concern for Others and Connection to Self — and reported a less hierarchical stance toward colleagues, alongside greater creativity and openness (“Altered States of Leadership,” Frontiers in Psychology, 2023).
Emotional empathy. In controlled laboratory work, a single dose of psilocybin measurably increased emotional empathy in healthy volunteers (Pokorny et al., 2017) — the raw material of the “EQ” every leadership book gestures at.
Openness that lasts. Johns Hopkins researchers found a single guided psilocybin session produced increases in the personality trait Openness that were still present more than a year later (MacLean et al., 2011) — one of the few documented interventions that durably moves a Big Five trait in adults.
Business schools are now studying this directly — the University of Maryland is currently testing whether psilocybin shifts executive decision-making patterns. Early field, honestly labeled. But the direction of the findings is consistent: these experiences tend to widen the lens people lead through.
What was whispered about a decade ago is now openly discussed in boardrooms, founder circles, and executive-coaching practices. Not recreation — optimization. High performers have started treating guided psychedelic work the way they treat everything else that gives an edge: deliberately, privately, and with a plan.
The trend started where high stakes meet high burnout. Silicon Valley founders popularized microdosing as a focus and creativity tool; from there it moved into finance, medicine, law, and the C-suite. Executive retreats built specifically around guided sessions now run waitlists, with leaders paying five figures to step out of the machine and reset. Business media that once treated the subject as fringe — Fortune, The Wall Street Journal, Forbes — now cover it as a leadership-development story.
Academia followed the money and the interest. The University of Maryland’s business school is running a study on whether psilocybin shifts executive decision-making patterns — the hypothesis being that it makes leaders more open to innovation and more emotionally connected. It is early, and we won’t oversell it. But the direction is unmistakable: the people whose entire job is finding an edge have decided this is one.
Here is the part that matters, though. The same drive that makes this appealing is what makes doing it carelessly dangerous. Booking a retreat off an Instagram ad, skipping the screening, treating a profound tool like a productivity hack — that is how a good decision becomes a bad one. The leaders who get real value from this treat it with the same rigor they’d apply to any serious decision: proper medical screening, a vetted setting, and integration afterward. That rigor is exactly what we exist to provide.
Time-boxed, legal-first, or root-cause — the right answer depends on your situation, and that’s a conversation.
The option that fits between meetings — evidence-backed for depression and anxiety, no travel required.
Explore Ketamine →For alcohol or opioid dependence, or a hard reset: one supervised week abroad instead of a year of white-knuckling.
Explore Ibogaine →The shortest of the major experiences — for the leader whose problem is meaning and perspective, not a diagnosis.
Explore 5-MeO-DMT →The most-researched path for depression and existential rumination — the compound behind the openness and connection findings.
Explore Psilocybin →Where burnout is really unprocessed trauma or a fractured relationship, MDMA-assisted therapy works on the wound underneath.
Explore MDMA →Nobody books this to feel a certain way on a Tuesday. They book it because something that used to work has stopped — the drive, the sleep, the patience, the sense that any of it still means something. When it lands, the change rarely looks dramatic from the outside. It looks like a person who came back to themselves. Here is what our clients tend to name first:
Not the espresso kind. The steady, underlying drive that was there before “running on empty” quietly became the baseline — and that you’d half-forgotten was optional.
Decisions stop feeling like fog-of-war. The signal separates from the noise, the important things get loud again, and second-guessing stops eating the hours between them.
The nightcap that became three, the 3am dread, the autopilot you drive your own life on — back in proportion, or gone. Not white-knuckled. Reset.
The people you built all of this for stop getting the leftover version of you. Presence at dinner. Patience you didn’t have to fake. The reason under the ambition, back in view.
Every operator knows the machine can’t be rebuilt while it’s running flat out. You schedule maintenance for everything you own — except the person running it. A guided psychedelic experience is, among other things, the deepest scheduled maintenance available: a structured pause that strips the noise, shows you the patterns you’ve been too busy to see, and reconnects you to the reasons underneath the work.
That’s not soft. Self-awareness, empathy, and clarity under pressure are the leadership curriculum — every coach and every business school says so. What a well-held session offers is a direct route to the material the curriculum circles: who you are when the title comes off, what you actually want, and what the pace has been costing. Leaders come back from that work with something no offsite produces — a quieter head and a wider lens.
Nothing you share moves to any provider — or anyone else — until you explicitly say so.
One phone line, one advisor, no intake team passing your file around. Records stay with us. Introductions happen when you decide they happen, and a clinic learns your name only when you're ready to be known. If you've built a career on managing information, this process will feel familiar — because it's built the same way.
Ketamine programs run locally, scheduled around your week. Ibogaine and 5-MeO-DMT programs run five to ten days abroad — less time than most leadership offsites.
The planning is the point: timing against quarters and board cycles, medication tapers built around real obligations, integration calls that respect a calendar. Burnout convinced you there's no room to deal with this. The room exists — it just has to be designed.
Call or text (866) 435-7057. One line, one person — not a call center, not a CRM sequence.
Your calendar, your board meetings, your medications, your risk tolerance — planning starts from your life as it is.
Cardiac and psychiatric work-up coordinated around your schedule, before any program is considered.
Nothing about you moves to any provider until you say so. You decide when a clinic learns your name.
Integration support that fits a working life — scheduled calls, not open-ended programs.
Completely — it's the first pillar of how we work. Nothing you share with us goes to any provider until you say so, and nothing about your inquiry is visible to anyone else. Many of our clients are people whose names get recognized; discretion is a design requirement, not a courtesy.
More than you'd think. Ketamine programs run around a work schedule. Ibogaine and 5-MeO-DMT programs abroad typically run 5–10 days — a sabbatical week, not a leave of absence. We help you plan the calendar as carefully as the treatment.
Often, yes. High-functioning professionals are overrepresented in alcohol dependence, and ibogaine is best known for interrupting exactly that cycle — with the caveat that its serious risks concentrate in unscreened, pre-existing heart conditions, which is why the cardiac work-up at a legitimate clinic is non-negotiable.
Ketamine is legal in the U.S. under medical supervision. Ibogaine, 5-MeO-DMT, and psilocybin programs operate legally in other jurisdictions, and traveling to them is not a crime — but licensing boards vary in what they ask. We'll flag the questions worth asking a lawyer before you commit; we don't practice law.
Ketamine therapy is legal and FDA-recognized in the U.S. Ibogaine, 5-MeO-DMT, MDMA, and psilocybin are accessed through licensed or regulated programs abroad, or in U.S. clinical-research settings. We map exactly what’s legal, where, and what that means for your risk profile — nothing gray gets glossed over.
It can, which is precisely why screening comes first. SSRIs, stimulants, blood-pressure medication, and sleep aids all interact with these treatments. A proper medical work-up — coordinated discreetly, on your schedule — builds any needed taper with physician oversight rather than leaving you to improvise.
It happens, and we’d rather set that expectation than sell a miracle. These are tools, not switches. The people who get the most treat preparation and integration as seriously as the session itself — and part of our job is making sure you go in with realistic aims and real support for afterward.
You mostly can’t, from a website — which is the entire reason we exist. We’ve evaluated programs against a published standard: medical screening, staffing, emergency readiness, aftercare, and honest pricing. You get vetted introductions, not search results.
Tell us what’s actually going on — the version you can’t say at work. An advisor maps your options, timelines, and costs, and nothing moves until you say so.
Speak With An Advisor →Plan 7–10 days away for ibogaine programs, 3–5 for psilocybin or 5-MeO-DMT retreats, plus preparation calls before and integration after.
Yes. We do not bill insurance or contact employers; clinic records stay with the clinic. Privacy is a system: travel, communication and follow-up are planned that way.
Most professionals report clearer thinking and energy within weeks; the first days after treatment are for rest, not decisions. Plan the return accordingly.
Call or text (866) 435-7057 or request a consultation. Conversations are confidential and there is no obligation.
